Clinical Trial Update: Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated Fatigue [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating the safety and preliminary efficacy of meldonium in patients with metastatic renal cell carcinoma and cancer-related fati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Fatigue
• Renal Cell Carcinoma

Drugs mentioned

• Meldonium (meldonium)

Snippet

Sponsor: Kidney Cancer Research Bureau | Conditions: Renal Cell Cancer Metastatic, Kidney Cancer | Phase 1, Phase 2 | Status: COMPLETED